Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 21, 2022
- Accession no.
- 0001104659-22-006488
- Filed
- Jan 21, 2022
- Trade date
- Jan 20, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.23M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Common Stock | MOption exerciseAcquired | +1,094 | $111.00 | +$121,434 | 31,463 | Direct | |
| Jan 20, 2022 | Common Stock | MOption exerciseAcquired | +4,906 | $111.00 | +$544,566 | 36,369 | Direct | |
| Jan 20, 2022 | Common Stock | SSaleDisposed | −2,581 | $204.79F2 | −$528,562.99 | 33,788 | Direct | |
| Jan 20, 2022 | Common Stock | SSaleDisposed | −1,709 | $205.82F3 | −$351,746.38 | 32,079 | Direct | |
| Jan 20, 2022 | Common Stock | SSaleDisposed | −1,710 | $206.51F4 | −$353,132.1 | 30,369 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Common Stock | MOption exerciseDisposed | −1,094 | $0.00 | $0 | 54,000 | Direct | |
| Jan 20, 2022 | Common Stock | MOption exerciseDisposed | −4,906 | $0.00 | $0 | 22,552 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $204.2050 to $205.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $205.24 to 206.2250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $206.26 to $206.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.